Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 SGD | 0.00% | 0.00% | -37.50% |
Apr. 29 | Clearbridge Health Awards Shares Under Performance Share Plan | MT |
Feb. 29 | Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 16.41M 12.12M | Sales 2023 | 11.49M 8.48M | Capitalization | 9.9M 7.31M |
---|---|---|---|---|---|
Net income 2022 | -11M -8.12M | Net income 2023 | -32M -23.63M | EV / Sales 2022 | 1.49 x |
Net Debt 2022 | 913K 674K | Net Debt 2023 | 2.5M 1.85M | EV / Sales 2023 | 1.08 x |
P/E ratio 2022 |
-2.11
x | P/E ratio 2023 |
-0.31
x | Employees | 121 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.05% |
3 months | -16.67% | ||
6 months | -28.57% | ||
Current year | -37.50% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 17-05-14 |
Wei Chee Tan
AUD | Comptroller/Controller/Auditor | 39 | 22-09-30 |
Hui Yee Cheok
SEC | Corporate Secretary | - | 22-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 17-05-14 |
Mark Ryan
BRD | Director/Board Member | 57 | 17-11-19 |
Andrew Lord
BRD | Director/Board Member | 65 | 17-11-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.01 | 0.00% | 2,219,000 |
24-05-08 | 0.01 | 0.00% | 619,100 |
24-05-07 | 0.01 | -9.09% | 5,095,100 |
24-05-06 | 0.011 | +10.00% | 8,120,600 |
24-05-03 | 0.01 | 0.00% | 314,600 |
Delayed Quote Singapore S.E., May 09, 2024 at 04:21 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-37.50% | 4.58M | |
+20.68% | 84.31B | |
-29.31% | 69.9B | |
+9.65% | 29.06B | |
-8.63% | 17.38B | |
+2.14% | 17.01B | |
+0.39% | 15.35B | |
+6.47% | 12.91B | |
+68.23% | 12.47B | |
+6.43% | 12.26B |
- Stock Market
- Equities
- 1H3 Stock